Skinvisible Statistics
Total Valuation
Skinvisible has a market cap or net worth of 1.44 million. The enterprise value is 7.17 million.
| Market Cap | 1.44M |
| Enterprise Value | 7.17M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Skinvisible has 5.40 million shares outstanding. The number of shares has increased by 16.02% in one year.
| Current Share Class | 5.40M |
| Shares Outstanding | 5.40M |
| Shares Change (YoY) | +16.02% |
| Shares Change (QoQ) | -19.06% |
| Owned by Insiders (%) | 3.52% |
| Owned by Institutions (%) | n/a |
| Float | 5.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 72.14 |
| PB Ratio | -0.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.90 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.94 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -250.14% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 14.76% |
| Revenue Per Employee | 10,000 |
| Profits Per Employee | -278,144 |
| Employee Count | 2 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.97% in the last 52 weeks. The beta is 1.63, so Skinvisible's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -85.97% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.43 |
| Relative Strength Index (RSI) | 66.60 |
| Average Volume (20 Days) | 30 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, Skinvisible had revenue of 20,000 and -556,287 in losses. Loss per share was -0.11.
| Revenue | 20,000 |
| Gross Profit | 20,000 |
| Operating Income | -606,257 |
| Pretax Income | -556,287 |
| Net Income | -556,287 |
| EBITDA | -585,574 |
| EBIT | -606,257 |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 13,396 in cash and 5.74 million in debt, giving a net cash position of -5.73 million or -1.06 per share.
| Cash & Cash Equivalents | 13,396 |
| Total Debt | 5.74M |
| Net Cash | -5.73M |
| Net Cash Per Share | -1.06 |
| Equity (Book Value) | -9.48M |
| Book Value Per Share | -1.75 |
| Working Capital | -4.22M |
Cash Flow
| Operating Cash Flow | -89,263 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -3,031.29% |
| Pretax Margin | -2,781.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Skinvisible does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.02% |
| Shareholder Yield | n/a |
| Earnings Yield | -38.56% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 4, 2019. It was a reverse split with a ratio of 0.02.
| Last Split Date | Jan 4, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
Skinvisible has an Altman Z-Score of -423.51 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -423.51 |
| Piotroski F-Score | 3 |